Related references
Note: Only part of the references are listed.miR-153 Supports Colorectal Cancer Progression via Pleiotropic Effects That Enhance Invasion and Chemotherapeutic Resistance
Lei Zhang et al.
CANCER RESEARCH (2013)
Downregulation of miR-153 contributes to epithelial-mesenchymal transition and tumor metastasis in human epithelial cancer
Qin Xu et al.
CARCINOGENESIS (2013)
MicroRNAs: key players of taxane resistance and their therapeutic potential in human cancers
Shi-Yun Cui et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2013)
MicroRNA-153 is tumor suppressive in glioblastoma stem cells
Shiguang Zhao et al.
MOLECULAR BIOLOGY REPORTS (2013)
Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer
Ziqing Wu et al.
PROSTATE (2013)
MiR-34a chemosensitizes bladder cancer cells to cisplatin treatment regardless of p53-Rb pathway status
Ruth L. Vinall et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
miR-153 sensitized the K562 cells to As2O3-induced apoptosis
Li Liu et al.
MEDICAL ONCOLOGY (2012)
miR-337-3p and Its Targets STAT3 and RAP1A Modulate Taxane Sensitivity in Non-Small Cell Lung Cancers
Liqin Du et al.
PLOS ONE (2012)
MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14)
R. Wang et al.
ONCOGENE (2011)
Modulation of K-Ras-Dependent Lung Tumorigenesis by MicroRNA-21
Mark E. Hatley et al.
CANCER CELL (2010)
Cancer Statistics, 2009
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2009)
miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 Downregulation
Michela Garofalo et al.
CANCER CELL (2009)
Dithiolethione compounds inhibit Akt signaling in human breast and lung cancer cells by increasing PP2A activity
C. H. Switzer et al.
ONCOGENE (2009)
MiR-107 and MiR-185 Can Induce Cell Cycle Arrest in Human Non Small Cell Lung Cancer Cell Lines
Yukari Takahashi et al.
PLOS ONE (2009)
Phosphorylated Akt overexpression and loss of PTEN expression in non-small cell lung cancer confers poor prognosis
JM Tang et al.
LUNG CANCER (2006)
Perturbations of the AKT signaling pathway in human cancer
DA Altomare et al.
ONCOGENE (2005)
A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation
Y Hayashita et al.
CANCER RESEARCH (2005)
Response of non-small cell lung cancer cells to the inhibitors of phosphatidylinositol 3-kinase/Akt- and MAPK kinase 4/c-jun NH2-terminal kinase pathways:: An effective therapeutic strategy for lung cancer
HY Lee et al.
CLINICAL CANCER RESEARCH (2005)
Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival
J Takamizawa et al.
CANCER RESEARCH (2004)
Phospho-Akt overexpression in non-small cell lung cancer confers significant stage-independent survival disadvantage
O David et al.
CLINICAL CANCER RESEARCH (2004)
Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression
J Hutchinson et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Share Paper
